Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
3570
Clinical Trial Start Date
2009
0Primary Completion Date
2010
0Study Completion Date
2010
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Drug0
Interventional Trial Phase
Phase 30
Official Name
A Clinical Safety and Efficacy Evaluation of Zylet® Versus Tobradex in the Treatment of Blepharokeratoconjunctivitis0
Last Updated
February 28, 2012
0Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
Single0
Masked Party
Investigator0
Other attributes
Intervention Treatment
Loteprednol and tobramycin0
Tobramycin and dexamethasone0
Study summary
This study is to evaluate the safety and efficacy of loteprednol etabonate \[LE\] and tobramycin ophthalmic suspension versus tobramycin and dexamethasone ophthalmic suspension in the treatment of ocular inflammation associated with blepharokeratoconjunctivitis (BKC).
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
